Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement.
- Rabe E Department of Dermatology, University of Bonn, Bonn, Germany.
- Partsch H Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Morrison N Center for Vein Restoration, Mesa, AZ, USA.
- Meissner MH Department of Surgery, Harborview Medical Center, Seattle, WA, USA.
- Mosti G Angiology Department, Clinica MD Barbantini, Lucca, Italy.
- Lattimer CR Josef Pflug Vascular Laboratory, West London Vascular and Interventional Centre, Ealing Hospital & Imperial College, London, UK.
- Carpentier PH Centre de Recherche Universitaire de La Léchère, Equipe THEMAS, Université Joseph Fourier, Grenoble, France.
- Gaillard S SIGVARIS Management AG, Winterthur, Switzerland.
- Jünger M Department of Dermatology, University of Greifswald, Greifswald, Germany.
- Urbanek T Department of General Surgery, Vascular Surgery, Angiology and Phlebology, Medical University of Silesia, Katowice, Poland.
- Hafner J Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
- Patel M First Choice Vascular, Swastik Society, Ahmedabad, India.
- Wu S Department of Podiatric Surgery & Applied Biomechanics, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
- Caprini J Department of Vascular Surgery, The University of Chicago, Chicago, IL, USA.
- Lurie F Department of Vascular Surgery, University of Michigan, Ann Arbor, MI, USA.
- Hirsch T Practice for Internal Medicine and Vascular Diseases, Halle, Germany.
- 2020-03-04
Published in:
- Phlebology. - 2020
English
OBJECTIVES
Medical compression therapy is used for non-invasive treatment of venous and lymphatic diseases. Medical compression therapy-associated adverse events and contraindications have been reported, although some contraindications are theoretically based. This consensus statement provides recommendations on medical compression therapy risks and contraindications.
METHODS
A systematic literature search of medical compression therapy publications reporting adverse events up until November 2017 was performed. A consensus panel comprising 15 international experts critically reviewed the publications and formulated the recommendations.
RESULTS
Sixty-two publications reporting medical compression therapy adverse events were identified. The consensus panel issued 21 recommendations on medical compression therapy contraindications and adverse event risk mitigation, in addition to reviewing medical compression therapy use in borderline indications. The most frequently reported non-severe medical compression therapy-associated adverse events included skin irritation, discomfort and pain. Very rare but severe adverse events, including soft tissue and nerve injury, were also identified.
CONCLUSION
This consensus statement summarises published medical compression therapy-associated adverse events and contraindications, and provides guidance on medical compression therapy. Severe medical compression therapy-associated adverse events are very rarely encountered if compression is used correctly and contraindications are considered.
Medical compression therapy is used for non-invasive treatment of venous and lymphatic diseases. Medical compression therapy-associated adverse events and contraindications have been reported, although some contraindications are theoretically based. This consensus statement provides recommendations on medical compression therapy risks and contraindications.
METHODS
A systematic literature search of medical compression therapy publications reporting adverse events up until November 2017 was performed. A consensus panel comprising 15 international experts critically reviewed the publications and formulated the recommendations.
RESULTS
Sixty-two publications reporting medical compression therapy adverse events were identified. The consensus panel issued 21 recommendations on medical compression therapy contraindications and adverse event risk mitigation, in addition to reviewing medical compression therapy use in borderline indications. The most frequently reported non-severe medical compression therapy-associated adverse events included skin irritation, discomfort and pain. Very rare but severe adverse events, including soft tissue and nerve injury, were also identified.
CONCLUSION
This consensus statement summarises published medical compression therapy-associated adverse events and contraindications, and provides guidance on medical compression therapy. Severe medical compression therapy-associated adverse events are very rarely encountered if compression is used correctly and contraindications are considered.
- Language
-
- English
- Open access status
- hybrid
- Identifiers
-
- DOI 10.1177/0268355520909066
- PMID 32122269
- Persistent URL
- https://sonar.ch/global/documents/284309
Statistics
Document views: 41
File downloads:
- Full-text: 0